hVIVO is amplifying the UK Health Security Agency’s crucial advice on maintaining good hand hygiene as a powerful defence against the spread of seasonal illnesses. With respiratory infections on the rise, experts urge simple preventative measures to protect communities and vulnerable groups alike.
Dr Conall Watson, consultant epidemiologist at the agency, reinforced the importance of minimising contact with others when exhibiting symptoms like fever, cough, or fatigue. He further advised that those with respiratory illnesses consider wearing face masks in public spaces, especially during flu season when viral circulation is at its peak.
As we navigate the colder months, HVivo underscores the critical role these practical actions play in safeguarding public health. By adopting these habits, individuals contribute to a collective effort to reduce illness and maintain wellbeing.
hVIVO plc (formerly Open Orphan plc), led by Cathal Friel, is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and antivirals using human challenge clinical trials, providing end-to-end early clinical development services for its broad and long-standing client base of biopharma companies.
